Benefit-Risk Assessment of Tolterodine in the Treatment of Overactive Bladder in Adults

ISSN： 0114-5916

Source： Drug Safety, Vol.27, Iss.13, 2004-01, pp. : 1043-1057

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tolterodine for the treatment of overactive bladder

By Salvatore Stefano Serati Maurizio Bolis Pierfrancesco

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 7, 2008-05 ,pp. : 1249-1255

Informa Healthcare

Access to resources Recommend Favorite

Tolterodine for the treatment of overactive bladder: a review

By Rovner Eric S

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 4, 2005-04 ,pp. : 653-666

Informa Healthcare

Access to resources Recommend Favorite

Tolterodine effective in the treatment of overactive bladder

Inpharma, Vol. 1, Iss. 1330, 2002-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite

Tolterodine: A Review of its Use in the Treatment of Overactive Bladder

By Clemett D. Jarvis B.

Drugs & Aging, Vol. 18, Iss. 4, 2001-04 ,pp. : 277-304

Adis International

Access to resources Recommend Favorite

Evidence for the efficacy and safety of tolterodine in the treatment of overactive bladder

By Abrams Paul

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 10, 2001-10 ,pp. : 1685-1701

Informa Healthcare

Access to resources Recommend Favorite